Table 2

Dose escalation scheme

CohortDose (μg/day)Patients, no.Patients on ≥8 weeksaCourses, no.
15.03317
27.54219
310.03310
412.53329
515.012535
  • a Only patients completing ≥8 weeks of therapy were considered evaluable for response.